BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 34751180)

  • 1. Diagnosis of invasive fungal disease in coronavirus disease 2019: approaches and pitfalls.
    White PL
    Curr Opin Infect Dis; 2021 Dec; 34(6):573-580. PubMed ID: 34751180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERC.
    Alexander BD; Lamoth F; Heussel CP; Prokop CS; Desai SR; Morrissey CO; Baddley JW
    Clin Infect Dis; 2021 Mar; 72(Suppl 2):S79-S88. PubMed ID: 33709131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients.
    Basile K; Halliday C; Kok J; Chen SC
    J Fungi (Basel); 2022 Jan; 8(1):. PubMed ID: 35049999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active Surveillance Program to Increase Awareness on Invasive Fungal Diseases: the French RESSIF Network (2012 to 2018).
    Bretagne S; Sitbon K; Desnos-Ollivier M; Garcia-Hermoso D; Letscher-Bru V; Cassaing S; Millon L; Morio F; Gangneux JP; Hasseine L; Favennec L; Cateau E; Bailly E; Moniot M; Bonhomme J; Desbois-Nogard N; Chouaki T; Paugam A; Bouteille B; Pihet M; Dalle F; Eloy O; Sasso M; Demar M; Mariani-Kurkdjian P; Robert V; Lortholary O; Dromer F;
    mBio; 2022 Jun; 13(3):e0092022. PubMed ID: 35499498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Performance of the Associates of Cape Cod STAT Assay for the Diagnosis of Invasive Fungal Disease in Critical-Care Patients with COVID-19.
    White PL; Price JS; Backx M
    J Clin Microbiol; 2021 Aug; 59(9):e0086921. PubMed ID: 34190576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).
    Lortholary O; Fernández-Ruiz M; Perfect JR
    J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii31-ii36. PubMed ID: 27880667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicians' knowledge of invasive fungal disease in China.
    Chen Y; Huang X; Qiu H; Cheng L; Yu Y; Ma X; Feng S; Li Q; Wu D; Huang W; Chen D; Lv X; Hu J; Wang J; Li J; Yang W; Zhan Q; Sun B; Wang M
    Mycoses; 2023 Aug; 66(8):723-731. PubMed ID: 37059587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Ruhnke M; Cornely OA; Schmidt-Hieber M; Alakel N; Boell B; Buchheidt D; Christopeit M; Hasenkamp J; Heinz WJ; Hentrich M; Karthaus M; Koldehoff M; Maschmeyer G; Panse J; Penack O; Schleicher J; Teschner D; Ullmann AJ; Vehreschild M; von Lilienfeld-Toal M; Weissinger F; Schwartz S
    Mycoses; 2020 Jul; 63(7):653-682. PubMed ID: 32236989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.
    Lerolle N; Raffoux E; Socie G; Touratier S; Sauvageon H; Porcher R; Bretagne S; Bergeron A; Azoulay E; Molina JM; Lafaurie M
    Clin Microbiol Infect; 2014 Nov; 20(11):O952-9. PubMed ID: 24861577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children.
    King J; Pana ZD; Lehrnbecher T; Steinbach WJ; Warris A
    J Pediatric Infect Dis Soc; 2017 Sep; 6(suppl_1):S12-S21. PubMed ID: 28927201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung and sinus fungal infection imaging in immunocompromised patients.
    Lamoth F; Prakash K; Beigelman-Aubry C; Baddley JW
    Clin Microbiol Infect; 2024 Mar; 30(3):296-305. PubMed ID: 37604274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-associated mucormycosis - "The Black fungus" with associated invasive aspergillosis and actinomycosis infection: Series of 5 cases in the Indian scenario.
    Menia R; Raychaudhuri S; Agarwal C; Taneja J
    Indian J Pathol Microbiol; 2023; 66(4):823-828. PubMed ID: 38084540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.
    Perfect JR; Cornely OA; Heep M; Ostrosky-Zeichner L; Mullane KM; Maher R; Croos-Dabrera R; Lademacher C; Engelhardt M; Chen C; Marty FM
    Mycoses; 2018 Jul; 61(7):420-429. PubMed ID: 29570857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital.
    Paul M; Sasidharan J; Taneja J; Chatterjee K; Abbas SZ; Chowdhury V; Das A
    Med Mycol J; 2022; 63(3):59-64. PubMed ID: 36047183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based analysis of attributable hospitalisation costs of invasive fungal diseases in haematological malignancy patients using data linkage of state-wide registry and costing databases: 2009-2015.
    Valentine JC; Morrissey CO; Tacey MA; Liew D; Patil S; Ananda-Rajah M
    Mycoses; 2020 Feb; 63(2):162-171. PubMed ID: 31715052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orofacial Mycoses in Coronavirus Disease-2019 (COVID-19): A Systematic Review.
    Samaranayake LP; Fakhruddin KS; Ngo HC; Bandara HMNM; Leung YY
    Int Dent J; 2022 Oct; 72(5):607-620. PubMed ID: 35367044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center.
    Lum L; Lee A; Vu M; Strasser S; Davis R
    Transpl Infect Dis; 2020 Dec; 22(6):e13361. PubMed ID: 32510755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [COVID-19 associated mucormycosis. A case in Argentina].
    Aparicio M; Tuculet B; Rivolier MG; Forte A; Vila A
    Medicina (B Aires); 2022; 82(2):304-307. PubMed ID: 35417397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Fungal Infections (Aspergillosis and Mucormycosis) in a Diabetic Mellitus Patient Leading to Maxillary Sinusitis as a Post-COVID Manifestation: First Case Report.
    Jawanda MK; Narula R; Gupta S; Sharma V; Gupta P; Kaur M
    Acta Medica (Hradec Kralove); 2021; 64(4):227-231. PubMed ID: 35285446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of using fungal DNA for the diagnosis of invasive mycoses.
    White PL; Alanio A; Brown L; Cruciani M; Hagen F; Gorton R; Lackner M; Millon L; Morton CO; Rautemaa-Richardson R; Barnes RA; Donnelly JP; Loffler J;
    Expert Rev Mol Diagn; 2022 Feb; 22(2):169-184. PubMed ID: 35130460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.